her2 and her3 alterations as therapeutic targets of increasing significance in solid tumors
Published 3 years ago • 383 plays • Length 51:24
Download video MP4
Download video MP3
Similar videos
-
1:27:49
biomarker testing for new therapeutic options targeting her2, her3, and trop2 in solid tumors
-
58:27
addressing key targets in advanced nsclc: her2-, her3-, and trop2-targeted therapies
-
1:13
her3 as a new target in the oncology field
-
58:30
the potential of her2-, her3-, and trop2-targeted therapies to address unmet needs in advanced nsclc
-
1:30:06
moving toward expanded precision treatment of her2- or her3-driven breast, gi, lung & other cancers
-
32:54
raising the bar in her2-positive breast cancer
-
1:35:31
leveraging targeted therapies to improve outcomes across the continuum of her2 breast cancer
-
1:31:37
personalizing treatment decisions in her2-altered breast cancer
-
1:34:19
drs. schalper, press, tarantino & wainberg discuss #her2, #her3, & #trop2: https://bit.ly/37bh4ek
-
1:38:56
taking aim at gi cancers with personalized her2 and other molecularly targeted therapies
-
1:18:52
her2-positive gastrointestinal cancers: new evidence and practical guidance with targeted agents
-
1:02:48
expanding treatment options in er /her2- breast cancer: serds, serms, sercas, and more
-
1:03:59
selecting and sequencing of her2-targeting therapies in her2-positive metastatic breast cancer
-
56:23
are you prepared for the new wave of adcs in nsclc? targeting her2, her3, trop2, and others
-
1:05:01
tackling the practicalities of antibody–drug conjugate therapy for solid tumors
-
1:25:22
a new view of the spectrum of her2 expression and significance of her2 low in breast cancer
-
3:24
evolving treatment options in er metastatic breast cancer
-
51:40
trop2-targeting adcs as new tools in the tnbc and hr /her2- breast cancer treatment arsenal
-
1:33:57
evaluating the evidence and parsing the practicalities of therapeutic choices in hr breast cancer
Clip.africa.com - Privacy-policy